Sitting in my mailbox last week was a sign of the times.
No, it wasn’t a political brochure or a notice about homes for sale in my neighborhood. It was a scientific journal, tightly wrapped in plastic, attesting to the evolving importance of genetics in the delivery of medical care.
“Circulation: Cardiovascular Genetics,” a journal of the American Heart Association, was launched this month to much fanfare, and has started arriving in the offices of physicians and the labs of researchers.
As the title suggests, the new publication will focus on the genetics of the cardiovascular system, exploring population genetics and biomarkers, pharmacogenetics, molecular genetics, genomics, proteomics, metabolomics and systems biology, among other pertinent topics.
In short, it delves into what those of us already firmly entrenched in the genetic testing industry have long known is the future of healthcare: genomics and personalized medicine.